Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $52.5 million.

  • Surgery Partners' Dividends Paid - Common rose 2589.93% to $52.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $216.9 million, marking a year-over-year increase of 3771.43%. This contributed to the annual value of $170.5 million for FY2024, which is 1670.09% up from last year.
  • Per Surgery Partners' latest filing, its Dividends Paid - Common stood at $52.5 million for Q3 2025, which was up 2589.93% from $54.0 million recorded in Q2 2025.
  • Surgery Partners' 5-year Dividends Paid - Common high stood at $62.3 million for Q1 2025, and its period low was $31.3 million during Q1 2021.
  • Its 5-year average for Dividends Paid - Common is $40.2 million, with a median of $36.3 million in 2022.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first plummeted by 1025.64% in 2023, then soared by 5382.72% in 2025.
  • Quarter analysis of 5 years shows Surgery Partners' Dividends Paid - Common stood at $33.5 million in 2021, then grew by 8.36% to $36.3 million in 2022, then decreased by 3.31% to $35.1 million in 2023, then soared by 37.04% to $48.1 million in 2024, then increased by 9.15% to $52.5 million in 2025.
  • Its last three reported values are $52.5 million in Q3 2025, $54.0 million for Q2 2025, and $62.3 million during Q1 2025.